Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancerRodrigo Arriagada, Ariane Dunant, Jean-Pierre Pignon, et al.British Journal of Cancer|December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumoursCatherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Vincent Haddad, Katharina Schmid, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancerNermine S Kamal, Jean-Charles Soria, Jean Mendiboure, et al.Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.Molecular Oncology|February 6, 2014
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancerXiaoli Ma, Vanessa Rousseau, Haiji Sun, et al.Anti-Cancer Drugs|April 2, 2004
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neckJean-Pierre Pignon, Nathalie Syz, Marshall Posner, et al.Cancer Immunology, Immunotherapy : CII|August 28, 2020
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancerAlexandra Leary, Catherine Genestie, Félix Blanc-Durand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.Clinical & Experimental Metastasis|August 18, 2016
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapyCyrus Chargari, Renaud Mazeron, Ariane Dunant, et al.Pageof 6